Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial-Reference-Cited by-同舟云学术

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial

Published:2021-09 Issue:9 Volume:8 Page:e568-e580
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Madhi Shabir A,Koen Anthonet L,Izu Alane,Fairlie Lee,Cutland Clare L,Baillie Vicky,Padayachee Sherman D,Dheda Keertan,Barnabas Shaun L,Bhorat Qasim Ebrahim,Briner Carmen,Aley Parvinder K,Bhikha Sutika,Hermanus Tandile,Horne Elizea,Jose Aylin,Kgagudi Prudence,Lambe Teresa,Masenya Masebole,Masilela Mduduzi,Mkhize Nonhlanhla,Moultrie Andrew,Mukendi Christian K,Moyo-Gwete Thandeka,Nana Amit J,Nzimande Ayanda,Patel Faeezah,Rhead Sarah,Taoushanis Carol,Thombrayil Asha,van Eck Samuel,Voysey Merryn,Villafana Tonya L,Vekemans Johan,Gilbert Sarah C,Pollard Andrew J,Moore Penny L,Kwatra Gaurav

Funder

Bill and Melinda Gates Foundation

South African Medical Research Council

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference19 articles.

1. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial;Folegatti;Lancet,2020

2. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials;Voysey;Lancet,2021

3. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial;Ramasamy;Lancet,2021

4. Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa;Tegally;medRxiv,2020

5. Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa;Madhi;N Engl J Med,2021

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Causal Inference of the Effect of Vaccination on COVID-19 Disease Severity and Need for Intensive Care Unit Admission Among Hospitalized Patients in an African Setting;Cureus;2024-08-25

2. SARS-CoV-2-specific T-cell responses are induced in people living with human immunodeficiency virus after booster vaccination;Chinese Medical Journal;2024-07-18

3. Neutralizing antibody responses assessment after vaccination in people living with HIV using a surrogate neutralization assay;BMC Immunology;2024-07-10

4. SARS-CoV-2 humoral immunity in people living with HIV-1;Trends in Immunology;2024-07

5. Serum SARS-CoV-2 antibodies in HIV-1-infected patients after inactivated vaccination and SARS-CoV-2 infection;Heliyon;2024-06